Insider Transactions in Q1 2024 at Envista Holdings Corp (NVST)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,705
+20.21%
|
-
|
Feb 25
2024
|
Amir Aghdaei Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,570
+13.52%
|
-
|
Feb 25
2024
|
Amir Aghdaei Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,367
-11.3%
|
$734,074
$22.65 P/Share
|
Feb 25
2024
|
Eric Conley SVP, Orthodontics |
BUY
Grant, award, or other acquisition
|
Direct |
7,730
+12.55%
|
-
|
Feb 25
2024
|
Eric Conley SVP, Orthodontics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,241
-2.62%
|
$27,302
$22.65 P/Share
|
Feb 25
2024
|
Robert Befidi President, Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
9,385
+17.83%
|
-
|
Feb 25
2024
|
Mischa Reis SVP, Strategy & Bus. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
16,565
+27.56%
|
-
|
Feb 25
2024
|
Mischa Reis SVP, Strategy & Bus. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,134
-13.29%
|
$90,948
$22.65 P/Share
|
Feb 25
2024
|
Stephen Keller Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,045
+32.87%
|
-
|
Feb 25
2024
|
Stephen Keller Principal Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,562
-11.95%
|
$34,364
$22.65 P/Share
|
Feb 25
2024
|
Mark E Nance General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,530
+27.08%
|
-
|
Feb 25
2024
|
Mark E Nance General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-6.66%
|
$57,200
$22.65 P/Share
|
Feb 25
2024
|
Faez C Kaabi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,915
+40.92%
|
-
|
Feb 25
2024
|
Faez C Kaabi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,505
-9.89%
|
$33,110
$22.65 P/Share
|
Feb 15
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,225
+39.17%
|
-
|